MOG and myeloid sarcoma: If MOG-IgG seropositivity is not considered to constitute per se a “better explanation” [46], i.e., based solely on clinicoradiological criteria, 15/46 or 33 % of the patients with available data met the most current diagnostic criteria for MS [46] (Table 1).